StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) shareholders

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.53−0.23 (-4.83%)

Close on Nov 13, 2026Market cap $4.54MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
2.2%
0M of 5M shares
Institutional holders
5
5 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
6 buys · 5 sales
Net sold $323.07K

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SHPHValueChange% of portfolio
Hrt Financial LP78,5971.65%$255.00KNew0.00%
Citadel Advisors LLC24,3540.51%$79.15KNew0.00%
Barclays PLC7500.02%$2.44KNew0.00%
Tower Research Capital LLC (TRC)3890.01%$1.26KNew0.00%
Wall Street Access Asset Management, LLC1200.00%$390New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202650M2.2%5 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of SHPHValue% of fundAs of
Blackstone Alternative Multi-Strategy Fund-100-0.00%-$325-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ryan TrasoliniCo-Chief Executive Officer––Jun 1, 2026
Yuying LiangChief Financial Officer––Jan 12, 2026
Timothy J. LorberChief Financial Officer227,6354.78%Aug 12, 2025
Chris CooperInterim Co-CEO––Apr 2, 2025
Angel LirianoDirector0–Oct 29, 2025
Arachchige Sachin Eranga PathigodaDirector0–Oct 28, 2025
Adam V. ChambersDirector0–Sep 8, 2025
Steven M. RichardsDirector210,0044.41%Aug 13, 2025
Joseph TungDirector184,1623.87%Aug 12, 2025
George ScorsisDirector184,1623.87%Aug 12, 2025
Oleh NabytDirector184,1623.87%Aug 12, 2025
Joshua SchaferDirector210,0044.41%Feb 6, 2025
Milton BrownDirector346,6177.27%Feb 5, 2025
Financial Lp Hrt10% owner0–Jul 15, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Financial Lp Hrt
10% owner
Jul 14, 2026Sale−82,116$4.48$367.88K0
Financial Lp Hrt
10% owner
Jul 13, 2026Sale−1,033$4.67$4.82K60,238
Financial Lp Hrt
10% owner
Jul 10, 2026Buy+731$3.11$2.27K61,271
Financial Lp Hrt
10% owner
Jul 9, 2026Buy+8,266$3.38$27.94K60,540
Financial Lp Hrt
10% owner
Jul 8, 2026Sale−18,531$3.52$65.23K52,274
Financial Lp Hrt
10% owner
Jul 7, 2026Sale−10,580$3.33$35.23K70,805
Financial Lp Hrt
10% owner
Jul 6, 2026Sale−9,022$3.51$31.67K81,385
Financial Lp Hrt
10% owner
Jul 2, 2026Buy+7,851$3.54$27.79K90,407
Financial Lp Hrt
10% owner
Jul 1, 2026Buy+3,959$3.30$13.06K82,556
Financial Lp Hrt
10% owner
Jun 30, 2026Buy+6,755$3.23$21.82K78,597
Financial Lp Hrt
10% owner
Jun 29, 2026Buy+25,836$3.44$88.88K71,842
Joshua Schafer
Director
Dec 31, 2024Award+209,790––210,004
Steven M. Richards
Director
Dec 31, 2024Award+209,790––210,004
Steven M. Richards
Director
Dec 23, 2024Award+209,790––210,004
Joshua Schafer
Director
Dec 23, 2024Award+209,790––210,004
Milton Brown
Director
Dec 23, 2024Award+209,790––346,617
Mira Jung
Chief Scientific Officer
May 1, 2024Award−598$11.28$6.75K135,715
Hoek Michael Vander
Chief Financial Officer
Mar 8, 2024Award+100,000––103,852
Milton Brown
Director
Dec 13, 2023Sale−2,921$0.46$1.34K1,094,610
Bette Jacobs
Director
Dec 13, 2023Sale−4,157$0.46$1.91K27,064
Anatoly Dritschilo
CEO and Chairman, Director, 10% owner
Aug 14, 2023Gift−2,100,000––1,104,407
Anatoly Dritschilo
CEO and Chairman, Director, 10% owner
Aug 14, 2023Gift+2,100,000––2,100,000
Chris Senanayake
Director
Dec 29, 2022Sale−1,626$1.61$2.62K2,791
Steven M. Richards
Director
Dec 29, 2022Sale−995$1.61$1.60K1,707
William Adkins
–
Dec 29, 2022Sale−995$1.61$1.60K184,071
Milton Brown
Director
Dec 29, 2022Sale−995$1.61$1.60K1,072,531
Anatoly Dritschilo
CEO and Chairman, Director, 10% owner
Dec 29, 2022Sale−8,372$1.61$13.48K1,085,200
Tyvin Rich
Chief Medical Officer
Dec 29, 2022Sale−1,414$1.61$2.28K2,429
Bette Jacobs
Director
Dec 29, 2022Sale−4,366$1.61$7.03K31,221
Mira Jung
Chief Scientific Officer
Dec 29, 2022Sale−328$1.61$5281,071,388
Hoek Michael Vander
Chief Financial Officer
Dec 29, 2022Sale−2,243$1.61$3.61K3,852
Peter Dritschilo
President and COO
Dec 29, 2022Sale−3,820$1.61$6.15K6,560

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
1.49%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-52.2%
From 0M shares
Short volume, 20 days
30.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Shuttle Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,309 shares on Aug 27, 2026 over the last 90 days.

See a number that looks wrong?